Quick Login
CLOSE X
FRR FAMILY
FRR BOSS NEW
TRAINEE MILLIONAIRE
FRR FOREX
FRRBOSS SHAREPRO
FRR RE-KYC
Equity
Home/ Are You A Trader/  Market Info/  Company Profile/  Quarterly Results

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE9269.00219 (+2.42 %)
PREV CLOSE (Rs.) 9050.00
OPEN PRICE (Rs.) 9149.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13021
TODAY'S LOW / HIGH (Rs.)9080.05 9269.75
52 WK LOW / HIGH (Rs.)5637.5 9148.05
NSE9239.00179 (+1.98 %)
PREV CLOSE( Rs. ) 9060.00
OPEN PRICE (Rs.) 9099.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 9239.00 (118)
VOLUME 773225
TODAY'S LOW / HIGH(Rs.) 9080.50 9270.00
52 WK LOW / HIGH (Rs.)5636.5 9150

Quarterly Results

Type
Quarters
GO
Select year
(Rs.in Million)
Particulars
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
30800.00
28310.00
26040.00
27150.00
Total Expenditure
18250.00
18970.00
17140.00
18270.00
PBIDT (Excl OI)
12550.00
9340.00
8900.00
8880.00
Other Income
640.00
1550.00
880.00
1450.00
Operating Profit
13190.00
10890.00
9780.00
10330.00
Interest
60.00
60.00
60.00
80.00
Exceptional Items
NA
NA
-740.00
NA
PBDT
13130.00
10830.00
8980.00
10250.00
Depreciation
1330.00
1200.00
1180.00
1130.00
Profit Before Tax
11800.00
9630.00
7800.00
9120.00
Tax
2780.00
2120.00
1970.00
2230.00
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
9020.00
7510.00
5830.00
6890.00
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
9020.00
7510.00
5830.00
6890.00
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
9020.00
7510.00
5830.00
6890.00
Equity Capital
530.00
530.00
530.00
530.00
Face Value (IN RS)
2.00
2.00
2.00
2.00
Reserves
NA
NA
NA
NA
Calculated EPS
34.04
28.34
22.00
26.00
Calculated EPS (Annualised)
136.15
113.36
88.00
104.00
No of Public Share Holdings
127733490.00
127733490.00
127733490.00
127723490.00
% of Public Share Holdings
48.12
48.12
48.12
48.11
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
40.75
32.99
34.18
32.71
PBIDTM%
42.82
38.47
37.56
38.05
PBDTM%
42.63
38.26
34.49
37.75
PBTM%
38.31
34.02
29.95
33.59
PATM%
29.29
26.53
22.39
25.38
 
Notes
Notes
Notes
Notes
Attention Investors KYC ASBA NOMINATION

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Privacy | Disclaimer | Copyright | Terms & Conditions | Investor Grievance | Advisory for Investor | Investor Charter And Complaints | Investor SEBI Scores |
Regulatory Information | Documents in Vernacular Languages | CDSL E-Voting | Link Pan and Aadhaar | Fund Transfer | Segregation And Monitoring Of Collateral At Client Level |
Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links
BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015
Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.
© 2015 FRR Shares. All Rights Reserved | Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :
Assamese Bengali Gujarati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "